FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for mupirocin (generic) from Glenmark Pharmaceuticals Inc., USA, related to an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo
• Staphylococcal Skin Infection
• Streptococcal Skin Infection

Drugs mentioned

• Mupirocin (Mupirocin)

Snippet

SUPPL AP for MUPIROCIN (MUPIROCIN)